Novo Nordisk Financials
| N1VO34 Stock | BRL 64.83 14.85 18.64% |
Novo |
Please note, the presentation of Novo Nordisk's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Nordisk's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Novo Nordisk's management manipulating its earnings.
| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | Novo All 1, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.novonordisk.com |
| Phone | 45 44 44 88 88 |
| Currency | BRL - Brazilian Real |
You should never invest in Novo Nordisk without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Novo Stock, because this is throwing your money away. Analyzing the key information contained in Novo Nordisk's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Novo Nordisk Key Financial Ratios
Novo Nordisk's financial ratios allow both analysts and investors to convert raw data from Novo Nordisk's financial statements into concise, actionable information that can be used to evaluate the performance of Novo Nordisk over time and compare it to other companies across industries.Novo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Novo Nordisk's current stock value. Our valuation model uses many indicators to compare Novo Nordisk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novo Nordisk competition to find correlations between indicators driving Novo Nordisk's intrinsic value. More Info.Novo Nordisk AS is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers reporting about 0.30 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Novo Nordisk AS is roughly 3.32 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Novo Nordisk by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Novo Nordisk's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Novo Nordisk AS Systematic Risk
Novo Nordisk's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Novo Nordisk volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Novo Nordisk AS correlated with the market. If Beta is less than 0 Novo Nordisk generally moves in the opposite direction as compared to the market. If Novo Nordisk Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Novo Nordisk AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Novo Nordisk is generally in the same direction as the market. If Beta > 1 Novo Nordisk moves generally in the same direction as, but more than the movement of the benchmark.
Novo Nordisk December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Novo Nordisk help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novo Nordisk AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novo Nordisk AS based on widely used predictive technical indicators. In general, we focus on analyzing Novo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novo Nordisk's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 10.24 | |||
| Value At Risk | (3.79) | |||
| Potential Upside | 3.49 |
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |